Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Shah Nimish P Create: Alert

All | News | Filings
Date FiledTypeDescription
07/17/2023 4 Shah Nimish P (Director) has filed a Form 4 on Apogee Therapeutics, Inc.
Txns: Bought 1,750,000 shares @ $17, valued at $29.8M
Granted 47,758 options to buy @ $17, valued at $811.9k
10/26/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/17/2022 4 Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns: Bought 4,674 shares @ $11.98, valued at $56k
Bought 170,292 shares @ $11.67, valued at $2M
10/11/2022 4 Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns: Bought 28,900 shares @ $12, valued at $346.8k
Bought 80,314 shares @ $11.89, valued at $954.9k
Bought 25,000 shares @ $11.85, valued at $296.3k
10/06/2022 4 Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns: Bought 223,100 shares @ $11.81, valued at $2.6M
10/03/2022 4 Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns: Bought 168,187 shares @ $9.92, valued at $1.7M
Bought 268,736 shares @ $11.27, valued at $3M
09/28/2022 4 Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on Tricida, Inc.
Txns: Bought 395,614 shares @ $8.56, valued at $3.4M
Bought 115,000 shares @ $9.38, valued at $1.1M
Bought 76,600 shares @ $9.92, valued at $759.9k
09/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/01/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/25/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/24/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/25/2021 4 Shah Nimish P (Director) has filed a Form 4 on Instil Bio, Inc.
Txns: Converted 5,100,866 shares @ $0
Converted 510,030 shares @ $0
Converted 430,431 shares @ $0
Converted 43,033 shares @ $0
Converted 480,716 shares @ $0
Bought 104,640 shares @ $20, valued at $2.1M
Bought 10,470 shares @ $20, valued at $209.4k
Bought 116,880 shares @ $20, valued at $2.3M
Bought 48,390 shares @ $20, valued at $967.8k
Bought 19,620 shares @ $20, valued at $392.4k
Converted 4,250,722 preferred shares @ $0
03/22/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/01/2021 4 Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Altimmune, Inc.
Txns: Disposed of 1,000,000 shares @ $0
Acquired 1,000,000 warrants @ $0.0001, valued at $100
08/18/2020 4 Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Unum Therapeutics Inc.
Txns: Bought 100,000 shares @ $2.3, valued at $230k
Bought 250,000 shares @ $2.57, valued at $642.5k
Bought 101,000 shares @ $2.62, valued at $264.6k
06/15/2020 4 Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Altimmune, Inc.
Txns: Bought 1,500,000 shares @ $7.54, valued at $11.3M
05/28/2020 4 Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on Altimmune, Inc.
Txns: Bought 309,453 shares @ $8.79, valued at $2.7M
Bought 390,547 shares @ $9.78, valued at $3.8M
Bought 125,162 shares @ $7.23, valued at $904.9k
Bought 277,000 shares @ $7.92, valued at $2.2M
Bought 27,763 shares @ $7.79, valued at $216.3k
Bought 173,711 shares @ $8.87, valued at $1.5M
12/16/2019 4 Venrock Healthcare Capital Partners III, L.P. (10% Owner) has filed a Form 4 on CONSTELLATION PHARMACEUTICALS INC
Txns: Bought 400,000 shares @ $34.5, valued at $13.8M
10/28/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/20/2019 4 Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on KalVista Pharmaceuticals, Inc.
Txns: Sold 500,000 shares @ $28.75, valued at $14.4M
03/14/2019 4 VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.
Txns: Bought 142,857 shares @ $0.7, valued at $100k
03/13/2019 4 Venrock Associates VII, L.P. (10% Owner) has filed a Form 4 on ShockWave Medical, Inc.
Txns: Converted 1,105,529 shares @ $0
Converted 1,016,492 shares @ $0
Converted 1,105,529 convertible preferred @ $0
Converted 1,016,492 convertible preferred @ $0
09/17/2018 4 VENROCK ASSOCIATES IV L P (10% Owner) has filed a Form 4 on Bellerophon Therapeutics, Inc.
Txns: Bought 75,000 shares @ $1.1888, valued at $89.2k
Bought 75,000 shares @ $1.23, valued at $92.3k
Bought 60,000 shares @ $1.1824, valued at $70.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy